Role of epithelial-mesenchymal transition in gastric cancer initiation and progression

World Journal of Gastroenterology

Volumn 20, Issue 18, 2014, Pages 5403-5410

  Peng, Zhao ^a   Wang, Chen Xiao ^a   Fang, Er Hu ^a   Wang, Guo Bin ^a   Tong, Qiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cancer stem cells; Epithelial mesenchymal transition; Gastric cancer; Tumor progression; Tumorigenesis

Indexed keywords

HERMES ANTIGEN; NERVE CELL ADHESION MOLECULE; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMAD PROTEIN; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER STEM CELL; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; HISTONE ACETYLATION; HUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TRANSCRIPTION REGULATION; TUMOR GROWTH; ANIMAL; CELL TRANSFORMATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84900386296     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i18.5403     Document Type: Article

References (85)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96 [PMID: 18287387 DOI: 10.3322/CA.2007.0010]
2. Zhu X, Li J. Gastric carcinoma in China: Current status and future perspectives (Review). Oncol Lett 2010; 1: 407-412 [PMID: 22966316]
3. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12: 17-20 [PMID: 16440411]
4. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007; 10: 75-83 [PMID: 17577615]
5. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005; 233: 706-720 [PMID: 15937929]
6. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelialmesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-981 [PMID: 16567498]
7. Montemayor-Garcia C, Hardin H, Guo Z, Larrain C, Buehler D, Asioli S, Chen H, Lloyd RV. The role of epithelial mesenchymal transition markers in thyroid carcinoma progression. Endocr Pathol 2013; 24: 206-212 [PMID: 24126800]
8. Liang Q, Li L, Zhang J, Lei Y, Wang L, Liu DX, Feng J, Hou P, Yao R, Zhang Y, Huang B, Lu J. CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression. Sci Rep 2013; 3: 2932 [PMID: 24121667 DOI: 10.1038/srep02932]
9. Zhao L, Li W, Zang W, Liu Z, Xu X, Yu H, Yang Q, Jia J. JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis. Clin Cancer Res 2013; 19: 6419-6429 [PMID: 24077348]
10. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890 [PMID: 19945376 DOI: 10.1016/j.cell.2009.11.007]
11. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429-1437 [PMID: 19487819 DOI: 10.1172/JCI36183]
12. Natalwala A, Spychal R, Tselepis C. Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J Gastroenterol 2008; 14: 3792-3797 [PMID: 18609701]
13. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-558 [PMID: 16098727]
14. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265-273 [PMID: 19262571 DOI: 10.1038/nrc2620]
15. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784 [PMID: 14679171]
16. Qiao Y, Jiang X, Lee ST, Karuturi RK, Hooi SC, Yu Q. FOXQ1 regulates epithelial-mesenchymal transition in human cancers. Cancer Res 2011; 71: 3076-3086 [PMID: 21346143 DOI: 10.1158/0008-5472]
17. Greaves M. Cancer stem cells: back to Darwin? Semin Cancer Biol 2010; 20: 65-70 [PMID: 20359535 DOI: 10.1016/ j.semcancer]
18. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111 [PMID: 11689955]
19. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009; 27: 1006-1020 [PMID: 19415765 DOI: 10.1002/stem.30]
20. Ryu HS, Park do J, Kim HH, Kim WH, Lee HS. Combination of epithelial-mesenchymal transition and cancer stem celllike phenotypes has independent prognostic value in gastric cancer. Hum Pathol 2012; 43: 520-528 [PMID: 22018628 DOI: 10.1016/j.humpath]
21. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469-480 [PMID: 17081971]
22. Barker N, Clevers H. Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology 2010; 138: 1681-1696 [PMID: 20417836 DOI: 10.1053/j.gastro.2010.03.002]
23. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H, van den Born M, Danenberg E, van den Brink S, Korving J, Abo A, Peters PJ, Wright N, Poulsom R, Clevers H. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010; 6: 25-36 [PMID: 20085740 DOI: 10.1016/j.stem.2009.11.013]
24. de Lau W, Barker N, Low TY, Koo BK, Li VS, Teunissen H, Kujala P, Haegebarth A, Peters PJ, van de Wetering M, Stange DE, van Es JE, Guardavaccaro D, Schasfoort RB, Mohri Y, Nishimori K, Mohammed S, Heck AJ, Clevers H. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 2011; 476: 293-297 [PMID: 21727895 DOI: 10.1038/nature10337]
25. Voon DC, Wang H, Koo JK, Chai JH, Hor YT, Tan TZ, Chu YS, Mori S, Ito Y. EMT-induced stemness and tumorigenicity are fueled by the EGFR/Ras pathway. PLoS One 2013; 8: e70427 [PMID: 23950932 DOI: 10.1371/journal.pone.0070427]
26. Kanzawa M, Semba S, Hara S, Itoh T, Yokozaki H. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells. Pathobiology 2013; 80: 235-244 [PMID: 23615002 DOI: 10.1159/000346843]
27. Furue M. Epithelial tumor, invasion and stroma. Ann Dermatol 2011; 23: 125-131 [PMID: 21747608 DOI: 10.5021/ ad.2011.23.2.125]
28. Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 2013; 27: 2192-2206 [PMID: 24142872 DOI: 10.1101/gad.225334.113]
29. Chan AO. E-cadherin in gastric cancer. World J Gastroenterol 2006; 12: 199-203 [PMID: 16482618]
30. Cai C, Yu JW, Wu JG, Lu RQ, Ni XC, Wang SL, Jiang BJ. [CD133 promotes the invasion and metastasis of gastric cancer via epithelial-mesenchymal transition]. Zhonghua Wei Chang Wai Ke Zazhi 2013; 16: 662-667 [PMID: 23888452]
31. Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci 2004; 1014: 155-163 [PMID: 15153430]
32. Izumiya M, Kabashima A, Higuchi H, Igarashi T, Sakai G, Iizuka H, Nakamura S, Adachi M, Hamamoto Y, Funakoshi S, Takaishi H, Hibi T. Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells. Anticancer Res 2012; 32: 3847-3853 [PMID: 22993328]
33. Li W, Liu C, Tang Y, Li H, Zhou F, Lv S. Overexpression of Snail accelerates adriamycin induction of multidrug resistance in breast cancer cells. Asian Pac J Cancer Prev 2011; 12: 2575-2580 [PMID: 22320957]
34. Sánchez-Tilló E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A, Postigo A. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 2012; 69: 3429-3456 [PMID: 22945800 DOI: 10.1007/s00018-012-1122-2]
35. Castro Alves C, Rosivatz E, Schott C, Hollweck R, Becker I, Sarbia M, Carneiro F, Becker KF. Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol 2007; 211: 507-515 [PMID: 17299729]
36. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155-166 [PMID: 11994736]
37. Peinado H, Ballestar E, Esteller M, Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004; 24: 306-319 [PMID: 14673164]
38. Hou Z, Peng H, Ayyanathan K, Yan KP, Langer EM, Longmore GD, Rauscher FJ. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAILdependent transcriptional repression. Mol Cell Biol 2008; 28: 3198-3207 [PMID: 18347060 DOI: 10.1128/MCB.01435-07]
39. Herranz N, Pasini D, Díaz VM, Francí C, Gutierrez A, Dave N, Escrivà M, Hernandez-Muñoz I, Di Croce L, Helin K, García de Herreros A, Peiró S. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol Cell Biol 2008; 28: 4772-4781 [PMID: 18519590 DOI: 10.1128/ MCB.00323-08]
40. Lin Y, Wu Y, Li J, Dong C, Ye X, Chi YI, Evers BM, Zhou BP. The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1. EMBO J 2010; 29: 1803-1816 [PMID: 20389281 DOI: 10.1038/emboj.2010.63]
41. De Craene B, van Roy F, Berx G. Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal 2005; 17: 535-547 [PMID: 15683729]
42. Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL, Crystal RG, de Herreros AG, Moustakas A, Pettersson RF, Fuxe J. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 2009; 11: 943-950 [PMID: 19597490 DOI: 10.1038/ ncb1905]
43. Ru GQ, Wang HJ, Xu WJ, Zhao ZS. Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis. Pathol Oncol Res 2011; 17: 341-347 [PMID: 21104359 DOI: 10.1007/s12253-010-9332-0]
44. Kang Y, Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118: 277-279 [PMID: 15294153]
45. Barnes RM, Firulli AB. A twist of insight-the role of Twistfamily bHLH factors in development. Int J Dev Biol 2009; 53: 909-924 [PMID: 19378251 DOI: 10.1387/ijdb.082747rb]
46. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC, Wu KJ. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10: 295-305 [PMID: 18297062 DOI: 10.1038/ncb1691]
47. Luo GQ, Li JH, Wen JF, Zhou YH, Hu YB, Zhou JH. Effect and mechanism of the Twist gene on invasion and metastasis of gastric carcinoma cells. World J Gastroenterol 2008; 14: 2487-2493 [PMID: 18442194]
48. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267-1278 [PMID: 11430829]
49. Huangyang P, Shang Y. Epigenetic regulation of epithelial to mesenchymal transition. Curr Cancer Drug Targets 2013; 13: 973-985 [PMID: 24168185]
50. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321: 209-213 [PMID: 2423876]
51. Jin B, Li Y, Robertson KD. DNA methylation: superior or subordinate in the epigenetic hierarchy? Genes Cancer 2011; 2: 607-617 [PMID: 21941617 DOI: 10.1177/1947601910393957]
52. Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de Water B, Cornelisse CJ, Cleton-Jansen AM. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 2006; 94: 661-671 [PMID: 16495925]
53. Zhao C, Bu X. Promoter methylation of tumor-related genes in gastric carcinogenesis. Histol Histopathol 2012; 27: 1271-1282 [PMID: 22936446]
54. Moghbeli M, Moaven O, Memar B, Raziei HR, Aarabi A, Dadkhah E, Forghanifard MM, Manzari F, Abbaszadegan MR. Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression. J Gastrointest Cancer 2014; 45: 40-47 [PMID: 24022108]
55. Lee KH, Hwang D, Kang KY, Lee S, Kim DY, Joo YE, Lee JH. Frequent promoter methylation of CDH1 in non-neoplastic mucosa of sporadic diffuse gastric cancer. Anticancer Res 2013; 33: 3765-3774 [PMID: 24023308]
56. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705 [PMID: 17320507]
57. Fujii S, Ochiai A. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells. Cancer Sci 2008; 99: 738-746 [PMID: 18377425 DOI: 10.1111/j.1349-7006.2008.00743.x]
58. Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006; 6: 846-856 [PMID: 17060944]
59. Orlando V. Polycomb, epigenomes, and control of cell iden-tity. Cell 2003; 112: 599-606 [PMID: 12628181]
60. Marmorstein R, Roth SY. Histone acetyltransferases: function, structure, and catalysis. Curr Opin Genet Dev 2001; 11: 155-161 [PMID: 11250138]
61. Liu YN, Lee WW, Wang CY, Chao TH, Chen Y, Chen JH. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 2005; 24: 8277-8290 [PMID: 16116478]
62. Tochigi N, Kishimoto T, Suyama T, Nagai Y, Nikaido T, Akikusa B, Virtudazo E, Yamaguchi M, Ishikura H. Regulatory role of hepatocyte nuclear factor-4alpha on gastric choriocarcinoma function. Exp Mol Pathol 2006; 80: 77-84 [PMID: 15990092]
63. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355 [PMID: 15372042]
64. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866 [PMID: 17060945]
65. Gong J, Li J, Wang Y, Liu C, Jia H, Jiang C, Wang Y, Luo M, Zhao H, Dong L, Song W, Wang F, Wang W, Zhang J, Yu J. Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer. Carcinogenesis 2014; 35: 497-506 [PMID: 24130168]
66. Hutchison J, Cohen Z, Onyeagucha BC, Funk J, Nelson MA. How microRNAs influence both hereditary and inflammatory-mediated colon cancers. Cancer Genet 2013; 206: 309-316 [PMID: 24042167 DOI: 10.1016/j.cancergen.2013.06.005]
67. Sun X, He Y, Huang C, Ma TT, Li J. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway. Cell Signal 2013; 25: 2805-2811 [PMID: 24041653 DOI: 10.1016/j.cellsig]
68. Díaz-Martín J, Díaz-López A, Moreno-Bueno G, Castilla MÁ, Rosa-Rosa JM, Cano A, Palacios J. A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition. J Pathol 2014; 232: 319-329 [PMID: 24122292 DOI: 10.1002/path.4289]
69. Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C, Zhang Q. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep 2013; 29: 1579-1587 [PMID: 23381389 DOI: 10.3892/or.2013.2267]
70. Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, Diosdado B, Grabsch H, Santos MA, Meijer G, Seruca R, Carvalho B, Oliveira C. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 upregulation in intestinal gastric cancer. J Pathol 2012; 228: 31-44 [PMID: 22450781 DOI: 10.1002/path.4032]
71. Zhang Z, Liu S, Shi R, Zhao G. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet 2011; 204: 486-491 [PMID: 22018270 DOI: 10.1016/j.cancergen.2011.07.004]
72. Matsuoka T, Yashiro M, Nishioka N, Hirakawa K, Olden K, Roberts JD. PI3K/Akt signalling is required for the attachment and spreading, and growth in vivo of metastatic scirrhous gastric carcinoma. Br J Cancer 2012; 106: 1535-1542 [PMID: 22531720 DOI: 10.1038/bjc.2012.107]
73. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-1657 [PMID: 12040186]
74. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 2003; 4: 257-262 [PMID: 14585353]
75. Zerlin M, Julius MA, Kitajewski J. Wnt/Frizzled signaling in angiogenesis. Angiogenesis 2008; 11: 63-69 [PMID: 18253847 DOI: 10.1007/s10456-008-9095-3]
76. Stemmer V, de Craene B, Berx G, Behrens J. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 2008; 27: 5075-5080 [PMID: 18469861 DOI: 10.1038/ onc.2008.140]
77. Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, Hou F, Ge J, Zhong M, Tang Y, Xia X, Chen Z. EphA2 promotes epithelialmesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Oncogene 2013; Epub ahead of print [PMID: 23752181 DOI: 10.1038/onc.2013.238]
78. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 465-471 [PMID: 9393997]
79. Massagué J. TGFbeta in Cancer. Cell 2008; 134: 215-230 [PMID: 18662538 DOI: 10.1016/j.cell.2008.07.001]
80. Shinto O, Yashiro M, Kawajiri H, Shimizu K, Shimizu T, Miwa A, Hirakawa K. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Br J Cancer 2010; 102: 844-851 [PMID: 20145621 DOI: 10.1038/sj.bjc.6605561]
81. Naber HP, Drabsch Y, Snaar-Jagalska BE, ten Dijke P, van Laar T. Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion. Biochem Biophys Res Commun 2013; 435: 58-63 [PMID: 23618854 DOI: 10.1016/j.bbrc]
82. Ono Y, Hayashida T, Konagai A, Okazaki H, Miyao K, Kawachi S, Tanabe M, Shinoda M, Jinno H, Hasegawa H, Kitajima M, Kitagawa Y. Direct inhibition of the transforming growth factor-β pathway by protein-bound polysaccharide through inactivation of Smad2 signaling. Cancer Sci 2012; 103: 317-324 [PMID: 22034928 DOI: 10.1111/j.1349-7006.2011.02133.x]
83. Espinoza I, Pochampally R, Xing F, Watabe K, Miele L. Notch signaling: targeting cancer stem cells and epithelial-tomesenchymal transition. Onco Targets Ther 2013; 6: 1249-1259 [PMID: 24043949]
84. Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, Miele L. Targeting Notch to target cancer stem cells. Clin Cancer Res 2010; 16: 3141-3152 [PMID: 20530696 DOI: 10.1158/1078-0432]
85. Timmerman LA, Grego-Bessa J, Raya A, Bertrán E, Pérez-Pomares JM, Díez J, Aranda S, Palomo S, McCormick F, Izpisúa-Belmonte JC, de la Pompa JL. Notch promotes epithelialmesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 2004; 18: 99-115 [PMID: 14701881]